Avadel Pharmaceuticals PLC (AVDL) — Cash Flow-to-Debt Ratio
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow-to-Debt Ratio of 0.23x as of September 2025, meaning its operating cash flow of $23.26 Million could theoretically repay 0% of its total liabilities ($101.22 Million) in one year. See AVDL FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Avadel Pharmaceuticals PLC Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Avadel Pharmaceuticals PLC across 29 annual periods. Also explore net asset growth rate of Avadel Pharmaceuticals PLC to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Avadel Pharmaceuticals PLC (1996–2024)
Year-by-year debt coverage analysis for Avadel Pharmaceuticals PLC. For market capitalisation and broader financial context, see AVDL company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.52x | $-46.91 Million | $90.39 Million | ▲ +68.9% |
| 2023 | -1.67x | $-128.51 Million | $76.96 Million | ▼ -265.6% |
| 2022 | -0.46x | $-70.30 Million | $153.93 Million | ▲ +0.1% |
| 2021 | -0.46x | $-77.31 Million | $169.02 Million | ▼ -40.2% |
| 2020 | -0.33x | $-48.73 Million | $149.37 Million | ▼ -53.8% |
| 2019 | -0.21x | $-38.33 Million | $180.63 Million | ▲ +51.9% |
| 2018 | -0.44x | $-82.72 Million | $187.52 Million | ▼ -543.5% |
| 2017 | 0.10x | $16.66 Million | $167.54 Million | ▲ +7.0% |
| 2016 | 0.09x | $18.90 Million | $203.41 Million | ▼ -83.8% |
| 2015 | 0.57x | $84.29 Million | $147.11 Million | ▲ +905.7% |
| 2014 | -0.07x | $-10.62 Million | $149.31 Million | ▲ +56.7% |
| 2013 | -0.16x | $-20.68 Million | $125.76 Million | ▲ +38.3% |
| 2012 | -0.27x | $-23.14 Million | $86.81 Million | ▼ -2.3% |
| 2011 | -0.26x | $-10.32 Million | $39.61 Million | ▼ -83.0% |
| 2010 | -0.14x | $-5.46 Million | $38.31 Million | ▼ -185.9% |
| 2009 | 0.17x | $8.20 Million | $49.43 Million | ▲ +195.6% |
| 2008 | -0.17x | $-7.51 Million | $43.31 Million | ▲ +57.9% |
| 2007 | -0.41x | $-19.24 Million | $46.77 Million | ▲ +42.3% |
| 2006 | -0.71x | $-29.83 Million | $41.87 Million | ▼ -38.5% |
| 2005 | -0.51x | $-19.39 Million | $37.70 Million | ▼ -257.6% |
| 2004 | -0.14x | $-4.15 Million | $28.85 Million | ▼ -141.4% |
| 2003 | 0.35x | $12.23 Million | $35.19 Million | ▼ -57.3% |
| 2002 | 0.81x | $8.77 Million | $10.79 Million | ▲ +410.5% |
| 2001 | -0.26x | $-2.78 Million | $10.63 Million | ▲ +55.9% |
| 2000 | -0.59x | $-5.62 Million | $9.48 Million | ▲ +18.1% |
| 1999 | -0.72x | $-4.24 Million | $5.85 Million | ▲ +33.4% |
| 1998 | -1.09x | $-8.19 Million | $7.53 Million | ▲ +12.1% |
| 1997 | -1.24x | $-8.90 Million | $7.20 Million | ▼ -100.1% |
| 1996 | -0.62x | $-4.20 Million | $6.80 Million | — |